MedTrace Logo

Prospective Multicenter Evaluation of the MycoGenie Kit for the Diagnosis of Invasive Aspergillosis

NCT03349931 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2025-11-20

No results posted yet for this study

Summary

The purpose of this study is to evaluate the performances of the real-time PCR ADEMTECH kit of DNA extraction and detection of Aspergillus fumigatus in serum samples in patients at high-risk for invasive aspergillosis (IA). DNA detection will be associated with detection of TR34/L98H mutations in cyp51A gene, which confer azole resistance.

Conditions

  • Invasive Aspergillosis in Patients With Onco-haematological Diseases

Interventions

DIAGNOSTIC_TEST

DNA extraction and detection of Aspergillus fumigatus in serum samples

Performances diagnostic test of the real-time PCR ADEMTECH kit of DNA extraction and detection of Aspergillus fumigatus in serum samples in patients at high-risk for invasive aspergillosis (IA).

Sponsors & Collaborators

  • Société ADEMTECH SA

    collaborator UNKNOWN

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Eric DANNAOUI, MD, PhD · Assistance Publique - Hôpitaux de Paris

  • Marie-Elisabeth BOUGNOUX, MD, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-05
Primary Completion
2020-01-20
Completion
2020-01-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03349931 on ClinicalTrials.gov